TGFB1 and cancer: This shift in NK cell function may be induced by several factors present in the breast TME, as previously described for lung cancer, where TGF-β, adenosine, and prostaglandins downregulate NK activating receptors and induce the production of VEGF and placental growth factor (PIGF) that promote cancer progression (55, 60, 61).